Cart
sales@molnova.com
Opevesostat
Opevesostat
Catalog No. M37000
Opevesostat (ODM-208) is an inhibitor of lyase (CYP11A1) (the enzyme cleavage cholesterol side chain).
| Size | Price / USD | Stock | Quantity |
| 2MG | 46 | Get Quote |
|
| 5MG | 61 | Get Quote |
|
| 10MG | 101 | Get Quote |
|
| 25MG | 182 | Get Quote |
|
| 50MG | 288 | Get Quote |
|
| 100MG | 417 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameOpevesostat
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Ikonen, et al. Method for treating prostate cancer in patient using CYP11A1 inhibitor as active ingredient. World Intellectual Property Organization, WO2023052682 A1. 2023-04-06.
molnova catalog
related products
-
Seviteronel
Seviteronel (VT-464) is a novel CYP17 cleavage enzyme inhibitor and androgen receptor antagonist used in breast and prostate cancer research.
-
Guan-fu base A
Guanfu base A is a potent noncompetitive CYP2D6 inhibitor (Ki: 1.20 μM in HLMs; Ki: 0.37 μM for rCYP2D6). It also inhibits HERG channel current.
-
Enerisant HCl
Enerisant HCl is a novel potent and selective histamine H3 receptor antagonist, a substrate for P-gp, mediated by cytochrome P450 (CYP) and transporter proteins.
